District Ventures Capital (District Ventures) announced today it has closed an equity investment with Premama Wellness (Premama), producers of a popular four-stage preconception through postnatal care supplement system based in Providence, Rhode Island. Read more >>
FutureFuel.io, making the implementation of student debt centric benefits easy has announced the launch of its category-defining offering: Giveback by FutureFuel.io. Read more >>
A Phenix City man is among the estimated 200,000 or less people in the United States with an inherited condition called Retinitis Pigmentosa. Moses Fryer was born with Retinitis Pigmentosa. He doesn’t know from whom in his family tree it originated...Fryer could either adapt or try one of the costly electronic glasses approved by the FDA. He chose the eSight glasses. Read more >>
This article first appeared on BostInno, a sister publication--The round was led by Forestay Capital, the technology innovation arm of Waypoint Capital, with participation from Wasabi’s previous investors. Read more >>
ZetrOZ Systems is pleased to announce the selection of Dr. George Lewis as a keynote speaker at the 2020 National Institutes of Health Pain Consortium Symposium. Read more >>
Xylyx Bio, a leader in predictive disease models, today announced the release of its IN SITE™ Metastasis Kit, a highly physiologic system that contains complex site-specific microenvironments to provide scientists with much-needed insight into cancer disease biology and the efficacy of drug candidates. Read more >>
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the publication of two abstracts at the European League Against Rheumatism (EULAR) 2020 E-Congress that will be taking place June 3-6, 2020. Read more >>
An inspiration and candid conversation between Dr. Mayasari Lim and upcoming 3DHEALS2020 speaker John O’Neil, Chief Scientific Officer of Xylyx, a New York-based startup focusing on creating the perfect cell environment for a variety of biotech process including biofabrication/bioprinting, and tissue engineering. Read more >>
Three early-stage investors spoke with the Greentown Labs community this month about different types of investors, how to build investor relationships, and advice for approaching fundraising in an uncertain economy. The panel, which was part of Greentown’s Investor Speaker Series, featured Deb Kemper, managing partner of Golden Seeds Ventures, Christopher Mirabile, chair emeritus and public policy chair emeritus of the Angel Capital Association, and Ziad H. Moukheiber, president and CEO of Boston Harbor Angels. Read more >>
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.